A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient

A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient

Remdesivir is a direct-acting inhibitor of SARS-CoV-2 RNA-dependent RNA polymerase that is used to treat severe COVID-19 infections. We report a patient with severe COVID-19 pneumonia who experienced palpitations and syncope two days after starting remdesivir therapy. The QTc interval was prolonged...

Full description

Bibliographic Details
Main Authors: Shmeylan Al Harbi, Mashael AlFaifi, Hasan M. Al-Dorzi, Ohoud Aljuhani, Abeer A. Alenazi, Mai Alalawi, Khalid Al Sulaiman
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:IDCases
Subjects:
Remdesivir
QTc prolongation
Coronavirus disease 2019 (Covid-19)
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250922002001

Internet

http://www.sciencedirect.com/science/article/pii/S2214250922002001

Similar Items